September 8, 2011 — A study in the journal Neurology International reveals a potentially treatable blood vessel abnormality in the brain may be the cause of Parkinson’s disease in some patients. A team of physicians and neuroscientists at Pittsburgh’s Allegheny General Hospital (AGH) conducted the study.

The study's lead author, Peter Jannetta, M.D., is credited with developing the modern surgical technique to treat such conditions. He is recognized worldwide as one of the preeminent authorities on diseases associated with vascular compression of cranial nerves.

Called microvascular decompression (MVD), the procedure involves repositioning compressive arteries in the brain and placing a protective pad between the artery and the structure it is compromising.

Jannetta first observed the possible role of vascular compression in Parkinson’s while treating a patient for the cranial nerve disease trigeminal neuralgia who also suffered from Parkinson’s. In addition to vascular compression of the left trigeminal nerve, the patient also had notable compression of an area of the brain called the left cerebral penduncle. The cerebral penduncles are two cylinder-like nerve bundles in the brainstem that act as a conduit for signals controlling motor functioning throughout the body.

After performing MVD of the left trigeminal nerve, Jannetta decompressed the patient's cerebral penduncle by mobilizing and repositioning the offending artery. The results were stunning. By post-operative day five, the patient's Parkinson's symptoms, including severe tremor and rigidity, had disappeared.

She remained symptom free for 18 months, after which she suffered a full recurrence. A follow-up magnetic resonance imaging (MRI) scan showed new compression of the non-treated right cerebral penduncle by the opposite posterior cerebral artery.

Based on this case, Jannetta and his AGH colleagues conducted a blinded MRI study analyzing the brains of 20 patients with Parkinson's and 20 healthy control subjects. The study showed 78 percent of the Parkinson's patients had visible arterial compression/distortion of one or both cerebral penduncles.

Of the study's 20 control subjects, just two had low-grade compression of the cerebral penduncle and one of those was subsequently diagnosed with Parkinson's.

A multi-center clinical trial to further explore the AGH team's premise has already been organized and is slated to begin later in 2011.

For more information: www.wpahs.org/locations/allegheny-general-hospital


Related Content

News | Radiology Imaging

Aug. 13, 2026 — Epic's new Care Everywhere Diagnostic Image Exchange allows health systems using Epic to share ...

Time August 21, 2026
arrow
News | Cardiac Imaging

Aug. 20, 2026 – The novel, radiopaque, polymer-based embolic coil from Embolization, Inc. has now surpassed 125 implants ...

Time August 20, 2026
arrow
News | PET Imaging

Aug. 18, 2026 — Cortech.AI's NeuroQuant PET has received FDA 510(k) clearance (K261916) for PET. NeuroQuant PET aids ...

Time August 18, 2026
arrow
News | Radiology Business

Aug. 4, 2026 — Canon Medical Systems USA (CMSU) has appointed Tsuneo "Neo" Imai as president and chief executive officer ...

Time August 10, 2026
arrow
News | Radiology Imaging

Aug. 4, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that the time between an imaging scan ...

Time August 06, 2026
arrow
News | Contrast Agents

Aug. 5, 2026 — Bracco Group is bringing a newly authorized macrocyclic gadolinium-based contrast agent (GBCA) for ...

Time August 05, 2026
arrow
News | PET Imaging

July 14, 2026 — New research is shedding new light on the biological basis of schizophrenia by directly measuring ...

Time July 15, 2026
arrow
News | Neuro Imaging

July 9, 2026 — Viz.ai has announced a collaboration with Cortechs.ai to integrate Cortechs.ai's NeuroQuant and ...

Time July 10, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Radiology Imaging

June 15, 2026 — Lead Glass Pro, a supplier of radiation shielding products, has expanded its turnkey installation ...

Time June 18, 2026
arrow
Subscribe Now